Invention Grant
- Patent Title: Treatment of cancer with larazotide derivatives in combination with immune checkpoint inhibitors
-
Application No.: US17239056Application Date: 2021-04-23
-
Publication No.: US11278587B2Publication Date: 2022-03-22
- Inventor: Jay Madan , Sandeep Laumas
- Applicant: 9 METERS BIOPHARMA, INC. , Institut Gustave Roussy
- Applicant Address: US NC Raleigh; FR Villejuif
- Assignee: 9 METERS BIOPHARMA, INC.,Institut Gustave Roussy
- Current Assignee: 9 METERS BIOPHARMA, INC.,Institut Gustave Roussy
- Current Assignee Address: US NC Raleigh; FR Villejuif
- Agency: Morgan, Lewis & Bockius LLP
- Main IPC: A61K38/08
- IPC: A61K38/08 ; A61K9/00 ; A61P35/00 ; A61K39/395 ; A61K39/00
Abstract:
The present invention provides compositions and methods for treating a patient having cancer, as well as methods for potentiating an immune checkpoint inhibitor therapy. The methods comprise administering larazotide or a derivative thereof such as (d)-larazotide to a subject in need, including subjects undergoing checkpoint inhibitor therapy, and subjects scheduled to undergo immune checkpoint inhibitor therapy.
Public/Granted literature
- US20210236586A1 COMPOSITIONS AND METHODS FOR POTENTIATING IMMUNE CHECKPOINT INHIBITOR THERAPY Public/Granted day:2021-08-05
Information query
IPC分类:
